Abstract
Objectives:
In this study, we used a discrete choice experiment (DCE) conducted August-October 2017 to examine electronic nicotine delivery systems (ENDS) product preferences in a national sample of adult smokers (N = 1154) who were also using ENDS or had not ruled out future use.
Methods:
The DCE evaluated 5 ENDS attributes: relative harm; effectiveness for helping smokers quit; nicotine strength; flavor; and price. We asked participants to choose among their own cigarettes, 2 ENDS products whose attributes varied across tasks, or none. We analyzed ENDS preferences using multinomial, nested, and mixed logit regressions.
Results:
Smokers preferred ENDS that are less harmful than cigarettes, are effective in helping smokers quit, are lower priced, and are not menthol-flavored. The marginal willingness to pay for an ENDS product was $8.40 when less harmful than cigarettes, $4.13 when of unknown effectiveness in helping quitting ($13.90 when effective), and $3.37 when ENDS are not menthol-flavored. Furthermore, the overall flavor preference is driven by tobacco smokers, not by menthol cigarette smokers who do prefer menthol-flavored ENDS.
Conclusions:
Policies that affect perceptions of ENDS effectiveness in promoting cessation and their relative harm may alter smokers’ ENDS preferences. Regulating flavors and price also may influence adult smokers’ ENDS preference.
Keywords: e-cigarettes, vaping, preference, attributes, discrete choice experiment
Regulation of electronic nicotine delivery systems (ENDS) is challenging given that ENDS as alternative tobacco products hold the potential to benefit smokers if they are indeed less harmful than cigarettes and smokers use them to quit smoking, versus the popularity of ENDS among youth and young adults who are attracted as new tobacco users.1 The US Food and Drug Administration (FDA), the agency tasked with regulating ENDS as a tobacco product, recognizes that tobacco products exist along a continuum of risk and that it is necessary to base regulatory decisions on research that sheds light on how regulatory actions influence product choices and the health risks in the population based on these choices.1,2 With ENDS, and possibly other new tobacco products, such as heated tobacco, that offer potential harm reduction benefits to smokers, regulators face an imposing challenge. They must weigh the potential benefits of reducing the harms associated with smoking by encouraging switching from cigarettes to a less harmful product, against the risk of increased youth adoption of the new products.2 A new paradigm is needed to understand how consumers react to ENDS, particularly about which product characteristics may motivate adult smokers to switch to ENDS.4
For adult smokers who would like to quit, whether ENDS products help with quitting is naturally an important determinant of use. According to the 2013–2014 Population Assessment of Tobacco and Health (PATH) survey, ENDS products were among the frequent methods used by smokers to quit.5 However, the evidence on whether ENDS are effective in helping cessation is conflicting. Whereas many longitudinal and review studies suggest that smokers who use ENDS are not more likely, and perhaps even less likely to quit smoking,6,7 other studies draw the opposite conclusion that smokers who initiate or use ENDS are more likely to quit.9–12 One randomized trial concluded that when accompanied by behavioral support and under advantageous conditions, ENDS are more effective for smoking cessation than nicotine-replacement therapy, which shows the promising effectiveness of ENDS in helping smokers quit.13
A report by National Academies of Sciences, Engineering, and Medicine (NASEM) has concluded that ENDS pose fewer harms to individual smokers than cigarettes.1 However, beliefs and perceptions of the relative harms of ENDS compared to cigarettes may deviate from the scientific evidence. Although generally ENDS are perceived to be less harmful than cigarettes by the public, a growing proportion of US adults believe ENDS to be as harmful or more harmful than cigarettes over time.14,15 Many US adults also wrongly believe that nicotine is the primary disease-causing chemical constituent,16 and thus, may misperceive the harms of ENDS. News articles also have mentioned the potential benefits of ENDS less often than their potential harm or risk.17 Therefore, perceptions regarding the relative harm of ENDS may play a significant role in smokers’ transitions from one tobacco product to another.
Furthermore, ENDS can be used with various levels of nicotine. E-liquid brands commonly offer a variety of nicotine strength, such as low, medium, and high.1,2 It is unclear how the nicotine strength of ENDS may influence smokers’ choice of tobacco product. It is important to understand whether nicotine strength is a factor that motivates smokers to try ENDS.
Another attribute that distinguishes ENDS from combustible cigarettes is characterizing flavor.1,2 Unlike cigarettes that are available in tobacco or menthol flavors only, ENDS provide a wide selection of flavors such as sweet, fruit, and others, with nearly unlimited combinations.18 Although studies show that flavors promote uptake among youth and young adults,19,20 the FDA and other stakeholders also recognize that they may be an important feature for leading smokers to switch to ENDS.2,21 However, several studies show that adult smokers in the US may prefer tobacco flavor to other flavors.22,23 Therefore, whereas flavors other than tobacco are appealing to youth, whether the abundance of ENDS flavors encourage older adult smokers to switch to ENDS is unknown.4
Many ENDS and cigarette attributes are subject to FDA regulation, such as characterizing flavors and nicotine strength.2 The FDA also oversees warning labels and product packaging that may shape the risk and harm perceptions of tobacco products. In light of evidence regarding the surge of ENDS use among young people,24 the US Surgeon General declared a vaping epidemic in December 2018.25,26 In the near future, there will be growing calls for tighter regulation over ENDS production, sales, and consumption. To evaluate the overall regulatory impacts beyond the youth and young adult populations, it is critical to understand how established smokers are influenced by ENDS attributes, thereby shedding light on the consequences of proposed and potential federal and local tobacco regulation.
This study used a Web-based discrete choice experiment (DCE) conducted among adult smokers to examine the effects of 5 important ENDS attributes on smokers’ product preferences: relative harm of ENDS compared with cigarettes, cessation effectiveness; nicotine strength; flavor; and price. There were several goals of this study. First, we sought to inform policymakers about the anticipated effects of potential regulations of ENDS. As described, the potential effects of relative harm, nicotine strength, and flavor on stated preference (use) will generate direct evidence to inform FDA regulation. Price, as one of the experimental attributes, allowed us to estimate marginal willingness-to-pay (WTP) for non-price attributes and to provide a standardized measure through which to compare our results with prior studies. Another motivation for characterizing the price sensitivity of smokers regarding ENDS use was that many state and local governments in the US had considered imposing taxes on ENDS, with its consequences yet to be assessed. Second, the perceived effectiveness of ENDS to help people quit, although being an important factor for switching, was rarely evaluated jointly with multiple attributes in a DCE setting. Our study evaluated the desirability of ENDS under different assumptions about the effectiveness of ENDS as a cessation aid. We further compared the importance of this attribute with the importance of other attributes. Third, this study added to the current debate on whether nicotine concentration or flavors influence adult smokers’ ENDS preferences, which is especially important to understand given the importance of these attributes as determinants of ENDS use.
METHODS
Discrete Choice Experiment
The discrete choice experiment (DCE) is a stated preference technique that has been used increasingly to examine preferences for tobacco products, including ENDS.27 DCEs are usually conducted using an online survey by presenting participants with a series of choices among different products.23 During the process, DCE elicits consumers’ preferences as a function of product attributes and their marginal WTP for these attributes. Because many tobacco attributes are directly or indirectly subject to federal and local regulation, DCE may help inform policymakers about the potential consequences of regulatory actions. For example, nicotine concentration/content and flavors are under the FDA’s regulatory authority, as are warning messages and advertising that may shape how the public perceives and characterizes the risks of a certain product.1,2
DCE Design and Attributes
We used a “labeled” DCE design and asked participants to choose among 3 options (Appendix 1): combustible cigarettes, 2 alternative vape pens to represent ENDS, and none of the above. Among these 3 options, combustible cigarettes and none of the above were opt-out options that did not vary within participant. To make choices more closely reflect real-world decisions, we gave the cigarette option the same characteristics as the cigarette product that participants self-reported currently smoking. Therefore, only the 2 ENDS products were generated by the DCE design. We adopted a labeled design, using generic label vape pens A and B, presented with their own cigarettes.28 The design of the DCE and the selection of the choice sets were conducted using SAS JMP11 using a D-optimal design.
The number of choice sets needed to identify the effects of attributes on ENDS preference among smokers depends on the number of attributes and their levels. Based on the existing literature,1,4 we identified 5 ENDS attributes that may affect smokers’ choice of ENDS products and their transition from cigarettes to ENDS (Table 1): relative harm compared with cigarettes, effectiveness with smoking cessation, nicotine strength, flavor, and price. We determined the levels for each of the 5 attributes based on a search of the literature and available options. Table 1 provides the levels of each attribute.
Table 1.
Discrete Choice Experiment (DCE) Attributes and Levels
Cigarettesa | Vape pen | |
---|---|---|
Less harmful to health than cigarettes | Yes [left blank] |
|
Effective for helping people quit | Effective | |
Not effective | ||
Unknown | ||
Nicotine strength | 12 mg per stick | None (0 mg) |
Low (1–12 mg) | ||
Medium (13–17 mg) | ||
High (18 mg or higher) | ||
Flavor | Tobaccob Mentholb |
Tobacco |
Menthol | ||
Fruit/candy/sweet/other flavors | ||
Price | Price per packb | Starter Kit: $30c |
Refill Price: | ||
$3 | ||
$5 | ||
$7 |
Note.
Cigarettes are taken as an opt-out option that does not vary within the same individuals.
Self-reported flavor (menthol or tobacco) and cigarette prices per pack.
Throughout the experiment, starter kit price is fixed at $30.
Because we offered one 2-level, 3 3-level, and one 4-level attributes, this design led to 216 (2 × 27 × 4) possible hypothetical products. As 2 alternative hypothetical products were needed to identify the effects of attributes on ENDS preference, the full factorial design rose to 23,220 (216 × 215 ÷ 2) potential combinations. We used SAS JMP 11 and a D-optimal design to generate efficient partial choice profiles that reduce the number of choice sets to 60, which were further divided into 5 versions, each containing 12 choice sets.29 The number of choice sets per participant was selected to be <16, the recommended maximum number of choice sets to prevent respondent fatigue.30,31
Randomization to Incentive Compatible Choices
We further introduced a reward mechanism to mitigate an acknowledged limitation of stated-preference approaches, namely that hypothetical actions may differ from real-world behavior (ie, hypothetical bias).32 Experimental economists have long believed that making choices “incentive compatible,” that is, compensating respondents for revealing their true preferences, are more valid than hypothetical choices.32 However, studies have found mixed evidence on the divergence between hypothetical versus real decisions in experimental tasks.33 In our study, we randomly assigned half of the participants to make incentive-compatible decisions, in which they were informed that we would select at random one respondent who would receive $100 worth of the product they choose for a randomly selected choice (question) or cash (Appendix 2). This is known as a “potentially real” choice, as opposed to a real choice in which all participants would receive one of their stated choices. The selected person actually received $100 cash. Thus, participants in the incentive-compatibility group maximized their well-being by selecting the products they really prefer. Our approach capitalized on the advantages of the DCE method while minimizing one of its major limitations using a novel elicitation approach.
Sample
From August through October 2017, we recruited through Gfk KnowledgePanel 1211 US adult smokers aged 18+ who had smoked at least 100 cigarettes in their lifetime and were either dual users of ENDS, or if they were not currently using ENDS, they reported not being completely certain that they would not use ENDS in the future. We dropped 57 persons whose self-reported cigarette prices are out of a plausible price range (lower than 2 dollars or higher than 30 dollars per pack). The final analytical sample consisted of 1154 participants, a sample size that exceeds what the DCE design calls for to detect the effects of attributes on preference.34 Only 15 participants (1.3%) chose none of the products in all choices.
Data Analysis
Multinomial, nested, and mixed logit models.
Following previous DCE studies,27 we employed 3 approaches to estimate the effects of the 5 attributes on ENDS preferences: multinomial logit, nested logit, and mixed (random parameter) models. All models also controlled for individual-level socio-demographic characteristics, including gender, age, marital status (married or not), race/ethnicity (white non-Hispanic, non-white and non-Hispanic, and Hispanic), household income (<$20,000; $20,000-$39,999; $40,000-$59,999; $60,000-$99,999; and ≥ $100,000), highest educational attainment (< high school, high school diploma, some college or Associate’s degree; and Bachelor’s Degree or higher), and tobacco use status measured by indicators for currently smoking cigarettes daily, currently using ENDS, and any past use of ENDS products, even one or 2 times. We also controlled for whether the participant was randomized to the incentive-compatibility condition. Standard errors were clustered at the individual level to account for correlation among choices made by the same individual. The regressions were weighted to represent the US adult smoker population.
The 3 logit models listed above have been used widely in analyzing choice data, with different assumptions about error structures.32 Conditional logit is the benchmark model for analyzing DCEs, which is an extension of the multinomial logit models in the context of choice behavior. Nested logit regression model decision trees or decision-making steps, with the first step choosing between the “opt-out” options (cigarettes or none of the above) and in the second step, which is conditional on not opting out, choosing between the 2 hypothetical ENDS products. Both methods can be expressed using the following equation for individual i and alternative j of an attribute:
where the 5 attribute variables are alternative-specific (ij) while socio-demographic and tobacco use variables (X) are individual-specific (i). Marginal WTP is measured as −α*/α4, where* represents a number corresponding to one of the other coefficients. For example, the marginal WTP for reduced harm of ENDS would be equal to −α1/α4. One potential limitation of conditional and nested logit models is that they rely on the independence of irrelevant alternatives (IIA) assumption: the choice between 2 alternatives is independent of a third alternative.35 Conducting likelihood-ratio tests can detect this problem. In this aspect, mixed logit has a clear advantage over conditional or nested logit models since it is robust to violations of the IIA assumption.35 In addition, mixed logit models take account of individual heterogeneity and thus will produce consistent estimates even when unobserved individual characteristics influence choice behaviors.36 The following modified equation was used to estimate the mixed logit model:
We estimated 2 alternative specifications by coding the attribute variables. The first specification used dummies to measure ENDS’ harm relative to cigarettes (a dummy for “less harmful to health than cigarettes,” with no information about relative harm as reference), flavor (fruit/candy/sweet/other flavors, menthol, with tobacco as reference), and ENDS’ effectiveness for helping people quit (effective, unknown, with not effective as reference), and treated nicotine strength (1- Low (1–12 mg), 2- Medium (13–17 mg), 3- High (18 mg or higher)), with None (0 mg) as reference) and price ($3, $5, and $7) as ordered or continuous variables. The second specification explored the nonlinearity of all attribute levels and coded the levels of nicotine strength and price into dummies as well.
Assessment of incentive compatibility.
We tested the difference in socio-demographic characteristics between the 2 groups by the randomized incentive-compatibility condition, and results suggested that these characteristics are similar for the 2 groups. We also examined the associations between randomization and the survey duration, which indicated that being randomized into the incentive condition was associated with spending more time on answering the survey. In addition, among participants who were randomized into the incentive compatibility condition, only 0.9% selected none of the above products for all 12 choices, whereas this percentage was 1.8% among those who did not see the incentive. These findings provide a rationale to include randomization to the incentive compatibility condition as a factor to predict choices.
RESULTS
Table 2 shows the weighted summary statistics of the analytical sample, including age, gender, household income, educational attainment, race/ethnicity, and marital status. Among cigarette smokers who were not ENDS rejecters, 76% were daily smokers, 77% were ENDS ever users, and 47% were current dual users of both ENDS and cigarettes. 51% of the participants were randomized into the condition of seeing the incentive.
Table 2.
Weighted Summary Statistics (N = 1154)
Variables | Mean (SD) or Percent (%) |
---|---|
Age | 41.3 |
(14.2) | |
Household income | |
< $20,000 | 25.7% |
$20,000 to $39,999 | 24.6% |
$40,000 to $59,999 | 15.8% |
$60,000 to $99,999 | 17.9% |
$100,000 or more | 16.1% |
Educational attainment | |
< high school | 21.8% |
High School diploma | 32.9% |
Some college or Associate’s degree | 32.3% |
Bachelor’s Degree or more | 13% |
Race/Ethnicity | |
White, non-Hispanic | 61.2% |
Non-white, non-Hispanic | 23.5% |
Hispanic | 15.4% |
Male gender | 46.9% |
Married | 49.9% |
Randomized to incentive compatibility | 50.7% |
Tobacco use status among smokers | |
Ever used ENDS, even one or 2 times | 76.7% |
Smoke daily | 76% |
Currently use ENDS | 46.7% |
Note.
SD = standard deviations
Table 3 presents the choice modeling results estimated using multinomial, nested, and mixed logit regressions. The results are mostly similar across the different logit models with different assumptions of the error structure. First, the coefficients of alternative-specific constants are negative and statistically significant, suggesting that smokers prefer cigarettes to ENDS or none of the products. Second, higher ENDS refill prices significantly reduced the probability of choosing the product.
Table 3.
ENDS Choices among Cigarettes Smokers (N = 55,012)
Models | Mixed Logit | Nested Logit | Multinomial Logit |
---|---|---|---|
Parameters | Coefficient (SE) | Coefficient (SE) | Coefficient (SE) |
Cigarettes (ref.) | |||
Vape pen 1: ASC | −2.240*** | −1.29*** | −2.047*** |
(0.507) | (0.383) | (0.387) | |
Vape pen 2: ASC | −2.412*** | −1.408*** | −2.107*** |
(0.578) | (0.387) | (0.59) | |
None of the above: ASC | −5.922*** | −3.77 | −2.473*** |
(0.899) | (1.978) | (0.63) | |
Non-price attribute 1: Less harmful to health than cigarettes (Blank as ref.) | |||
Yes | 0.39* | 0.356*** | 0.652*** |
(0.178) | (0.048) | (0.062) | |
[2.20] | |||
Non-price attribute 2: Effective for helping people quit (Not effective as ref.) | |||
Unknown | 0.444*** | 0.256*** | 0.32*** |
(0.095) | (0.051) | (0.067) | |
[0.082] | |||
Effective | 1.371*** | 0.623*** | 1.077*** |
(0.215) | (0.085) | (0.08) | |
[1.438] | |||
Non-price attribute 3: Flavor (Tobacco as ref.) | |||
Menthol | −0.518*** | −0.172** | −0.262** |
(0.135) | (0.06) | (0.095) | |
[0.008] | |||
Fruit/candy/sweet/other | −0.657*** | −0.006 | −0.008 |
(0.251) | (0.049) | (0.099) | |
[2.273] | |||
Non-price attribute 4: Nicotine Strength | |||
Nicotine Strength | −0.008 | −0.042* | −0.044 |
(0.081) | (0.017) | (0.039) | |
[0.475] | |||
Price attribute | −0.149*** | −0.08*** | −0.078*** |
(0.038) | (0.015) | (0.024) | |
[0.089] | |||
AIC | 27315 | 26674 | 26699 |
BIC | 27627 | 26923 | 27216 |
Log likelihood | −13622 | −13309 | −13292 |
p < .05,
p < .01,
p < .001
Note.
ASC = Alternative-specific constant.
Clustered standard errors adjusting for correlations within choices by the same individuals are in parentheses. Likelihood-ratio test for IIA: (2) = 534.36, p < .01. Hausman-McFadden test for IIA: (28) = 88.52, p < .01. Standard deviations of random coefficients are in brackets. For convergence, the mixed logit regressions only controlled for gender, age, education (< high school vs high school or more), income (<$20,000 vs above), race/ethnicity (white vs non-white) and ever used ENDS.
The coefficients of non-price attributes suggest that an ENDS product that is less harmful to health than cigarettes, compared with no such information given (ie, left blank), was associated with a higher probability of choosing the ENDS product. Compared with an ENDS product that is not effective in helping people quit, an ENDS product that is effective or with an unknown effectiveness was associated with a higher probability of choosing the product.
Compared with tobacco flavor, menthol flavor significantly reduced the probability of choosing ENDS. Mixed logit (random parameter logit) results indicate that fruit/candy/sweet/ other flavors, compared with a tobacco flavor, also significantly reduces the probability of choosing ENDS. However, this effect is not statistically significant in multinomial or nested logit regressions. In addition, to improve understanding of flavor preference, we conducted additional analyses stratified by current use of menthol cigarettes (results can be shared by request). Although the overall results suggest that smokers do not prefer menthol-flavored ENDS, stratified analyses indicate that this is driven by smokers of tobacco-flavored cigarettes and that smokers of menthol-flavored cigarettes do prefer menthol-flavored ENDS.
In regards to nicotine strength, nested logit regressions show that higher nicotine strength reduces the probability of choosing the ENDS product, but this effect is not statistically significant in multinomial or random parameter logit regressions. To summarize, smokers who are at least minimally open to trying ENDS prefer ENDS products that are less harmful to health than cigarettes, effective in helping people to quit, and have a lower refill price, and do not prefer menthol-flavored products and ones not effective in helping cessation.
The mixed logit results further indicate that the standard deviations for the coefficients of harm, other flavors, and nicotine strength are relatively large compared to the mean, suggesting heterogeneity in smokers’ preferences. In addition, the nested logit results suggest several socio-demographic characteristics and tobacco use status are associated with choosing ENDS over opt-out options (cigarettes or none of the above). These factors include currently using ENDS, non-daily smoking, and being non-white, non-Hispanic.
In Table 4, we present the marginal WTP estimates for non-price attributes using coefficients from the multinomial model, which is commonly used to estimate marginal WTP.37 The marginal WTP for an ENDS product that is less harmful to health than cigarettes is $8.40. The marginal WTP for an ENDS product with unknown effectiveness in helping cessation is $4.13, whereas for an ENDS product that is effective in helping cessation, the marginal WTP is $13.90. Marginal WTP for a tobacco flavor over a menthol flavor is $3.37. For smokers who are not rejecters of ENDS, a product that is effective in helping people to quit has the greatest impact in choosing ENDS.
Table 4.
Marginal Willingness to Pay (mWTP) Estimates for ENDS Attributes
Attributes | Reference | mWTP (SE) |
---|---|---|
Less harmful than cigarettes | Blank | $8.40 (2.79) |
Unknown effectiveness for cessation | Not effective for cessation | $4.13 (1.63) |
Effective for cessation | Not effective for cessation | $13.90 (1.29) |
Tobacco flavor | Menthol flavor | $3.37 (1.73) |
Note.
Standard errors were estimated using the delta method.
When comparing the Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) across models in Table 3, these statistics suggest that the nested logit regression model was the preferred model among the 3. Likelihood-ratio and Hausman-McFadden tests rejected that the IIA assumption held, suggesting that the nested logit is likely valid. We also conducted analyses using an alternative specification where all attribute levels were dichotomized (eg, refillable prices at $5 or $7, with $3 as the omitted category). The results for nested and multinomial logit models are presented in Appendix 3. Results for harm, effectiveness in helping cessation, and flavor were very similar to the benchmark specification presented in Table 3. We also conducted multinomial analyses using stratified samples by whether smokers currently also used ENDS (ie, dual use), which are presented in Appendix 4. Results pertaining to harm and effectiveness in helping cessation for both groups were similar to those shown in Table 3. The stratified analyses further illustrate that dual users’ preference for flavors did not significantly differ, whereas exclusive smokers did not prefer menthol flavored ENDS. Furthermore, AICs and BICs indicated that models treating nicotine strength and price as ordered or continuous (Table 3) fit data better than models treating them as dichotomous variables (Appendix 3).
DISCUSSION
We conducted a DCE among smokers who were not rejecters of ENDS. Our findings suggest that this population preferred ENDS that are less harmful to health than cigarettes, that are effective in helping people to quit smoking, and that have a lower refill price. They did not prefer products that are menthol flavored.
The attribute that had the most pronounced effect on choosing ENDS was its effectiveness in helping people to quit smoking. This finding is consistent with the existing evidence that using ENDS to reduce withdrawal symptoms or to help with quitting are the most commonly reported reasons for use.1 Smokers were willing to pay $13.90 for an ENDS product that was identified as effective in helping people to quit. Interestingly, we also found that smokers were more likely to choose ENDS products with an unknown cessation aid effectiveness, compared with a product that was identified as ineffective, and were willing to pay $4.13 for this attribute. There are several implications of these findings. First, the effectiveness of ENDS as a cessation aid perhaps is the most important factor that influences whether smokers will try or continue using ENDS. Second, given that many smokers use ENDS to help them quit, even without conclusive scientific evidence on its effectiveness, consumers may still have an interest to try. Policymakers may take this into account when considering regulation. If ENDS’ effectiveness in aiding quitting is the single most important incentive for smokers to switch, more stringent ENDS regulations affecting other attributes may still achieve an overall net public health benefit by preventing initiation while not eliminating smokers’ incentive to switch.
Adult smokers also valued ENDS as being a less harmful product than cigarettes and were willing to pay $8.40 for the reduced harm. In general, people perceived ENDS to be less harmful, indicating that this attribute would incentivize smokers to switch.1 However, growing evidence suggests that the risk and harm perceptions of ENDS have been shifting more negative.14 It is unclear what forces have driven this change, although the misperception of nicotine harm and more negative reports of ENDS on news media may have contributed.17
Furthermore, the FDA has required all ENDS products and advertisements to carry an addiction warning to convey the message that the product contains nicotine and nicotine is an addictive chemical.2 Existing evidence shows that the FDA warning unlikely impacts the risk perception of adult smokers, particularly when they are placed in advertisements.38–41 Therefore, the FDA warning may prevent ENDS initiation among non-tobacco users while not negatively affecting adult smokers’ incentive to switch. However, as several studies present, some ENDS brands, notably MarkTen, carry voluntary warnings that describe multiple harms of nicotine, which may cast a negative light on ENDS.42,43 Another potential policy option for the FDA to consider is to design warning messages that convey the relative harms of ENDS compared to cigarettes, though this would require more evidence on ENDS harms and appropriate communication strategies to ensure statements on relative harm information are accurately conveyed and understood as intended by the consumer.
With respect to flavors, we found that adult smokers were willing to pay $3.37 to have tobacco over menthol and other flavors in ENDS. This finding is consistent with the existing evidence that adult smokers prefer tobacco flavors in North America.22,23 We also conducted additional analyses and showed that menthol cigarette smokers preferred menthol flavored ENDS, whereas other smokers did not. These findings indicated that smokers prefer ENDS flavors that are same with their cigarette flavors and that there is heterogeneity in smokers’ preference for ENDS flavors as a result. Two DCE studies also showed the heterogeneity in flavor preference. One study indicated that young adult smokers prefer many flavors to tobacco flavor.21 The other study found a similar heterogeneity by age and showed that, whereas a cigarette menthol ban would lead to more switching from cigarettes to ENDS, banning flavors other than tobacco in both products may lead to increased cigarette smoking among adults.23 Nevertheless, flavors other than tobacco, particularly fruit/sweet/candy and other flavors, are a significant factor for youth and young adults to try ENDS.4,19 As the sweet / fruity flavors are more appealing for young people and may not be preferred by adult smokers, regulation banning the sale of certain flavored ENDS, particularly fruity or sweet ones, while keeping the relatively more appealing flavor profile of ENDS than cigarettes may achieve public health benefits.19
In this study, we did not find consistent evidence of smokers’ preferences for nicotine concentration in ENDS, which differs from what prior studies have reported.1,4 A systematic review suggested that smokers prefer medium and high nicotine ENDS.4,22 Future studies may explore the heterogeneity in the preference of nicotine strength.22
As with many prior studies, we found that smokers were sensitive to ENDS prices.21,23,37,43,44 The law of demand drives consumers’ choices between ENDS and cigarettes. Higher refill prices of ENDS reduced the probability of choosing ENDS. Some localities in the US have implemented ENDS excise taxes, such as Chicago.45 However, to encourage smokers to quit, a differential tax rate that favors ENDS (ie, lower taxes on ENDS than cigarettes) while keeping ENDS price high enough to deter youth initiation may benefit public health.46,47 Furthermore, if consumers prefer refillable devices, there is a fixed amount of initial investment on a starter kit, which can be expensive initially even if less expensive in the long run. Making these devices more affordable to smokers also may encourage them to switch.
Finally, we randomized half of the participants and created a financial incentive aimed at reducing the hypothetical bias in stated preference. We found that participants randomized into the incentive condition spent more time on answering the survey and were less likely to choose none of the products. Although the randomization did not significantly increase the likelihood that a smoker chooses ENDS, this certainly can imply that regardless of the randomization, all smoker participants in our experiment had a strong preference for cigarettes.
There are several limitations of this study. DCE is a stated preference technique that may not capture all real-world behaviors.35 In addition, although existing studies show substantial heterogeneity in ENDS preference by smokers’ age and sociodemographic characteristics, in this study, we did not explore the above heterogeneity.1 In future work, we will use Latent Class Analysis (LCA) to study heterogeneity in preferences and conduct policy simulations of potential regulations based on those results.35,37 Finally, whereas the level of nicotine contained in cigarettes and the level of nicotine concentration in ENDS may not be directly comparable, it is possible that some smokers mistakenly considered ENDS with high nicotine concentration to deliver more nicotine than a cigarette, and therefore, did not choose ENDS with a high nicotine concentration.
Nonetheless, this DCE study provides important evidence on adult smokers’ preference for ENDS attributes. Given that the US ENDS market has been rapidly evolving with newly invented products, such as nicotine salt-based products JUUL and Suorin Drop,48–51 future studies are needed to understand consumers’ preference for ENDS attributes of these increasingly popular products. Future studies may also apply DCEs to understand consumers’ preferences for emerging tobacco products in the global market.
IMPLICATIONS FOR TOBACCO REGULATION
ENDS effectiveness in promoting smoking cessation will increase smokers’ preference for ENDS. Policies that increase the perceived harmfulness of ENDS, increase ENDS prices, and decrease the availability of one’s preferred tobacco flavor in ENDS will decrease adult smokers’ preference for ENDS.
Acknowledgement
The project is funded by grant number P50DA036128 from the NIH/NIDA and FDA Center for Tobacco Products (CTP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. CS was also supported by the NIAAA grant 1K99AA024810. The authors thank Anh Ngo for excellent research assistance, and John Buckell for helpful comments.
Appendix 1. An Example of DCE Design
If you were choosing between the following scenarios and these were your only options, which would you choose?
Cigarettes | Vape Pen A | Vape Pen B | |
---|---|---|---|
Less harmful to health than cigarettes | Yes | Yes | |
Effective for helping people quit? | Unknown | Unknown | |
Nicotine strength | 12 mg per stick | High (18 mg or higher) | None (0 mg) |
Flavor | Menthol | Tobacco | Tobacco |
Price | Price per pack: $15.00 | Starter Kit: $30 | Starter Kit: $30 |
Refill Price: $3 | Refill Price: $3 |
- Cigarettes
- Vape Pen A
- Vape Pen B
- None of the Above
Appendix 2. Incentive Compatible Choices
At the end of this survey, we will select one person and one question at random. The selected person will actually receive $100 worth of the product they chose in the selected question. You should therefore answer these questions truthfully, so that you are awarded your preferred option if you are selected. |
For example, if you are selected as the winner and prefer the cigarette product over the vaping products in the selected question, then you would actually receive $100 of cigarettes. We reserve the right to provide $100 in cash instead. Please click here for official rules. |
Appendix 3. ENDS Choices among Cigarette Smokers (N = 55,012)
Models | Nested Logit | Multinomial Logit |
---|---|---|
Parameters | Coefficient (SE) | Coefficient (SE) |
Vape pen 1: ASC | −0.928* | −1.53*** |
(0.382) | (0.391) | |
Vape pen 2: ASC | −1.056** | −1.583** |
(0.385) | (0.594) | |
None of the above: ASC | −2.177 | −1.797** |
(2.617) | (0.59) | |
Non-price attribute 1: Less harmful to health than cigarettes (Blank as ref.) | ||
Yes | 0.36*** | 0.634*** |
(0.045) | (0.063) | |
Non-price attribute 2: Effective for helping people quit (Not effective as ref.) | ||
Unknown | 0.241*** | 0.28*** |
(0.05) | (0.071) | |
Effective | 0.615*** | 1.07*** |
(0.081) | (0.081) | |
Non-price attribute 3: Flavor (Tobacco as ref.) | ||
Menthol | −0.185*** | −0.284** |
(0.058) | (0.095) | |
Fruit/candy/sweet/other | −0.012 | −0.009 |
(0.05) | (0.103) | |
Non-price attribute 4: Nicotine Strength (None as ref.) | ||
Low | 0.07 | 0.094 |
(0.051) | (0.1) | |
Medium | −0.003 | 0.017 |
(0.054) | (0.114) | |
High | −0.126* | −0.141 |
(0.05) | (0.12) | |
Price attribute: ($3 as ref.) | ||
Price:$5 | −0.12** | −0.277*** |
(0.042) | (0.079) | |
Price:$7 | −0.337*** | −0.495*** |
(0.049) | (0.088) | |
AIC | 26699 | 26716 |
BIC | 26975 | 27260 |
Log likelihood | −13318 | −13297 |
p < .05,
p < .01,
p < .001
Note.
ASC = Alternative-specific constant.
Clustered standard errors adjusting for correlations within choices by the same individuals are in parentheses. Standard deviations of random coefficients are in brackets.
Appendix 4. ENDS Choices among Cigarette Smokers, Multinomial Logit Regressions
Models | Dual users (N=23,980) | Exclusive smokers (N=31,032) |
---|---|---|
Parameters | Coefficient (SE) | Coefficient (SE) |
Vape pen 1: ASC | −1.024* | −1.53*** |
(0.495) | (0.391) | |
Vape pen 2: ASC | −1.432* | −1.583** |
(0.725) | (0.594) | |
None of the above: ASC | −2.947*** | −1.797** |
(0.737) | (0.59) | |
Non-price attribute 1: Less harmful to health than cigarettes (Blank as ref.) | ||
Yes | 0.643*** | 0.646*** |
(0.085) | (0.091) | |
Non-price attribute 2: Effective for helping people quit (Not effective as ref.) | ||
Unknown | 0.235** | 0.352** |
(0.089) | (0.113) | |
Effective | 0.875*** | 1.324*** |
(0.105) | (0.12) | |
Non-price attribute 3: Flavor (Tobacco as ref.) | ||
Menthol | −0.161 | −0.53*** |
(0.136) | (0.127) | |
Fruit/candy/sweet/other | 0.126 | −0.223 |
(0.156) | (0.129) | |
Non-price attribute 4: Nicotine Strength (None as ref.) | ||
Low | 0.179 | 0.02 |
(0.145) | (0.126) | |
Medium | 0.109 | −0.098 |
(0.161) | (0.156) | |
High | −0.075 | −0.271 |
(0.162) | (0.182) | |
Price attribute: ($3 as ref.) | ||
Price:$5 | −0.266* | −0.253* |
(0.109) | (0.115) | |
Price:$7 | −0.575*** | −0.401** |
(0.111) | (0.136) | |
AIC | 13381 | 12741 |
BIC | 13826 | 13225 |
Log likelihood | −6636 | −6312 |
p < .05,
p < .01,
p < .001
Note.
ASC = Alternative-specific constant.
Clustered standard errors adjusting for correlations within choices by the same individuals are in parentheses. Standard deviations of random coefficients are in brackets.
Footnotes
Human Subjects Approval Statement
This study was approved by the Georgia State University Institutional Review Board.
Conflict of Interest Disclosure Statement
The authors have no conflicts of interest to disclose.
References
- 1.Eaton LD, Kwan YL, Stratton K. Public Health Consequences of E-cigarettes. National Academies of Sciences, Engineering, and Medicine. Washington, DC: National Academies Press; 2018. Available at: http://nationalacademies.org/hmd/reports/2018/public-health-consequences-of-e-cigarettes.aspx. Accessed November 22, 2019. [PubMed] [Google Scholar]
- 2.United States Department of Health and Human Services. Deeming tobacco products to be subject to the federal Food, Drug, and Cosmetic Act, as amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the sale and distribution of tobacco products and required warning statements for tobacco products; Final rule. Washington, DC: US Department of Health and Human Services, Office of Inspector General, May 2016. Docket No.FDA-2014-N-0189. Available at: https://www.federalregister.gov/documents/2016/05/10/2016-10685/deeming-tobacco-products-to-be-subject-to-the-federal-food-drug-and-cosmetic-act-as-amended-by-the. Accessed November 21, 2019. [PubMed] [Google Scholar]
- 3.Willett JG, Bennett M, Hair EC, et al. Recognition, use and perceptions of JUUL among youth and young adults. Tob Control. 2019;28(1):115–116. [DOI] [PubMed] [Google Scholar]
- 4.Zare S, Nemati M, Zheng YQ. A systematic review of consumer preference for e-cigarette attributes: flavor, nicotine strength, and type. PLoS One. 2018;13(3):e0194145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Rodu B, Plurphanswat N. Quit methods used by American smokers, 2013–2014. Int J Env Res Pub He. 2017;14(11):E1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Resp Med. 2016;4(2):116–128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Shi YY, Pierce JP, White M, et al. E-cigarette use and smoking reduction or cessation in the 2010/2011 TUS-CPS longitudinal cohort. BMC Public Health. 2016;16(1):1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Halpern SD, Harhay MO, Saulsgiver K, et al. A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation. New Engl J Med. 2018;378(24):2302–2310. [DOI] [PubMed] [Google Scholar]
- 9.Berry KM, Reynolds LM, Collins JM, et al. E-cigarette initiation and associated changes in smoking cessation and reduction: the Population Assessment of Tobacco and Health Study, 2013–2015. Tob Control. 2019;28(1):42–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zhu SH, Zhuang YL, Wong SS, et al. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ-Brit Med J. 2017;358:j3262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Levy DT, Yuan Z, Luo YY, Abrams DB. The relationship of e-cigarette use to cigarette quit attempts and cessation: insights from a large, nationally representative US survey. Nicotine Tob Res. 2018;20(8):931–939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Villanti AC, Feirman SP, Niaura RS, et al. How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor. Addiction. 2018;113(3):391–404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. New Engl J Med. 2019;380(7):629–637. [DOI] [PubMed] [Google Scholar]
- 14.Majeed BA, Weaver SR, Gregory KR, et al. Changing perceptions of harm of e-cigarettes among US adults, 2012–2015. Am J Prev Med. 2017;52(3):331–338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Huerta TR, Walker DM, Mullen D, et al. Trends in e-cigarette awareness and perceived harmfulness in the US. Am J Prev Med. 2017;52(3):339–346. [DOI] [PubMed] [Google Scholar]
- 16.Mumford EA, Pearson JL, Villanti AC, Evans WD. Nicotine and e-cigarette beliefs and policy support among US Smokers and Nonsmokers. Tob Regul Sci. 2017;3(3):293–304. [Google Scholar]
- 17.Wackowski OA, Giovenco DP, Singh B, et al. Content analysis of US news stories about e-cigarettes in 2015. Nicotine Tob Res. 2018;20(8):1015–1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Farsalinos KE, Romagna G, Tsiapras D, et al. Impact of flavour variability on electronic cigarette use experience: an internet survey. Int J Env Res Public Health. 2013;10(12):7272–7282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Harrell MB, Loukas A, Jackson CD, et al. Flavored tobacco product use among youth and young adults: what if flavors didn’t exist? Tob Regul Sci. 2017;3(2):168–173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Audrain-McGovern J, Strasser AA, Wileyto EP. The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers. Drug Alcohol Depen. 2016;166:263–267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Pesko MF, Kenkel DS, Wang H, Hughes JM. The effect of potential electronic nicotine delivery system regulations on nicotine product selection. Addiction. 2016;111(4):734–744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Czoli CD, Goniewicz M, Islam T, et al. Consumer preferences for electronic cigarettes: results from a discrete choice experiment. Tob Control. 2016;25(E1):E30–E36. [DOI] [PubMed] [Google Scholar]
- 23.Buckell J, Marti J, Sindelar JL. Should flavours be banned in cigarettes and e-cigarettes? Evidence on adult smokers and recent quitters from a discrete choice experiment. Tob Control. 2019;28:168–175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Jamal A, Gentzke A, Hu SS, et al. Tobacco use among middle and high school students -United States, 2011–2016. MMWR Morb Mortal Wkly Rep. 2017;66(23):597–603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.US Centers for Disease Control and Prevention. Surgeon General’s advisory on e-cigarette use among youth 2018. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/surgeon-general-advisory/index.html. Accessed November 21, 2019.
- 26.King BA, Gammon DG, Marynak KL, Rogers T. Electronic cigarette sales in the United States, 2013–2017. JAMA. 2018;320(13):1379–1380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Regmi K, Kaphle D, Timilsina S, Tuha NAA. Application of discrete-choice experiment methods in tobacco control: a systematic review. Pharmacoecon Open. 2018;2(1):5–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.de Bekker-Grob EW, Hol L, Donkers B, et al. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening. Value Health. 2010;13(2):315–323. [DOI] [PubMed] [Google Scholar]
- 29.Kessels R, Jones B, Goos P. Bayesian optimal designs for discrete choice experiments with partial profiles. J Choice Model. 2011;4(3):52–74. [Google Scholar]
- 30.Selivanova A, Krabbe PFM. Eye tracking to explore attendance in health-state descriptions. PLoS One. 2018;13(1):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bridges JFP, Hauber AB, Marshall D, et al. Conjoint analysis applications in health – a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14(4):403–413. [DOI] [PubMed] [Google Scholar]
- 32.Harrison GW. Making choice studies incentive compatible In Kanninen BJ, ed. Valuing Environmental Amenities Using Stated Choice Studies. Dordrecht, Germany: Springer; 2006:67–110. [Google Scholar]
- 33.Harrison GW, Rutström E. Experimental evidence on the existence of hypothetical bias in value elicitation methods In Plott CR, Smith VL, eds. Handbook of Experimental Economics Results Amsterdam, The Netherlands: North Holland; 2008:752–767. [Google Scholar]
- 34.de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient. 2015;8(5):373–384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hensher DA, Rose JM, Greene WH. Applied Choice Analysis. 2nd ed. Cambridge, UK: Cambridge University Press; 2015:706–741. [Google Scholar]
- 36.Marti J Assessing preferences for improved smoking cessation medications: a discrete choice experiment. Eur J Health Econ. 2012;13(5):533–548. [DOI] [PubMed] [Google Scholar]
- 37.Marti J, Buckell J, Maclean JC, Sindelar J. To “vape” or smoke? Experimental evidence on adult smokers. Econ Inq. 2019;57(1):705–725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Mays D, Smith C, Johnson AC, et al. An experimental study of the effects of electronic cigarette warnings on young adult nonsmokers’ perceptions and behavioral intentions. Tob Induc Dis. 2016;14:17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Berry C, Burton S, Howlett E. Are cigarette smokers’, e-cigarette users’, and dual users’ health-risk beliefs and responses to advertising influenced by addiction warnings and product type? Nicotine Tob Res. 2017;19(10):1185–1191. [DOI] [PubMed] [Google Scholar]
- 40.Mays D, Villanti A, Niaura RS, et al. The effects of varying electronic cigarette warning label design features on attention, recall, and product perceptions among young adults. Health Commun. 2019;34(3):317–324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Shang C, Weaver SR, Zahra N, et al. The association between potential exposure to magazine ads with voluntary health warnings and the perceived harmfulness of electronic nicotine delivery systems (ENDS). Int J Env Res Public Health. 2018;15(4):E575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lee YO, Shafer PR, Eggers ME, et al. Effect of a voluntary e-cigarette warning label on risk perceptions. Tob Regul Sci. 2016;2(1):82–93. [Google Scholar]
- 43.Huang JD, Tauras J, Chaloupka FJ. The impact of price and tobacco control policies on the demand for electronic nicotine delivery systems. Tob Control. 2014;23:41–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Huang JD, Gwarnicki C, Xu X, et al. A comprehensive examination of own- and cross-price elasticities of tobacco and nicotine replacement products in the US. Prev Med. 2018;117:107–114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Public Health Law Center. U.S. E-cigarette Regulation: A 50-State Review. St. Paul, MN: Mitchell Hamline School of Law; 2019. Available at: https://www.publichealthlaw-center.org/resources/us-e-cigarette-regulations-50-state-review. Accessed November 28, 2019. [Google Scholar]
- 46.Zheng YQ, Zhen C, Dench D, Nonnemaker JM. US demand for tobacco products in a system framework. Health Econ. 2017;26(8):1067–1086. [DOI] [PubMed] [Google Scholar]
- 47.Stoklosa M, Drope J, Chaloupka FJ. Prices and e-cigarette demand: evidence from the european union. Nicotine Tob Res. 2016;18(10):1973–1980. [DOI] [PubMed] [Google Scholar]
- 48.Morean ME, Camenga DR, Bold KW, et al. Querying about the use of specific e-cigarette devices may enhance accurate measurement of e-cigarette prevalence rates among high school students. Nicotine Tob Res. 2018. November 5. doi: 10.1093/ntr/nty240. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Hammond D, Wackowski OA, Reid JL, O’Connor RJ. Use of Juul e-cigarettes among youth in the United States. Nicotine Tob Res. 2018. October 27. doi: 10.1093/ntr/nty237. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Goniewicz ML, Boykan R, Messina CR, et al. High exposure to nicotine among adolescents who use Juul and other vape pod systems (‘pods’). Tob Control. 2019;28(6):676–677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Vallone DM, Bennett M, Xiao H, et al. Prevalence and correlates of JUUL use among a national sample of youth and young adults. Tob Control. 2019;28:603–609. [DOI] [PubMed] [Google Scholar]